Dr. Starbuck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2665 N Decatur Rd
Ste 630
Decatur, GA 30033Phone+1 404-778-3401
Summary
- I am a Gynecologic Oncologist in Atlanta GA. I have an interest in translational research and medical education, and work at Emory University, an academic practice that offers clinical trials. My research focus has focused on glycoprotein expression in ovarian cancer and the influence of chemokines in the ovarian cancer immune microenvironment.
Education & Training
- University at BuffaloFellowship, Gynecologic Oncology, 2016 - 2020
- Massachusetts General HospitalPost-Doctoral Fellowship, Gynecologic Oncology, 2014 - 2016
- The MetroHealth System/Case Western Reserve UniversityResidency, Obstetrics and Gynecology, 2010 - 2014
- Uconn School Of MedicineClass of 2010
- Tufts UniversityPost-Baccalaureate, Premedical Program, 2003 - 2004
- Brown UniversityBA, International Health, Esprit de Corps Award, 1999 - 2003
- Brown UniversityB.A., International Health, 1999 - 2003
- Boston UniversityNo Degree, Woods Hole Sea Semester Program, 2002
Certifications & Licensure
- GA State Medical License 2020 - 2025
- NY State Medical License 2016 - 2021
- MA State Medical License 2014 - 2016
- OH State Medical License 2010 - 2014
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- Tumor Biology Poster Award 2016
- Resident CREOG Award 2014
- Community Service Award Metrohealth-Case Western University, 2013
- Join now to see all
Publications & Presentations
PubMed
- 24 citationsAdoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies.P.C. Mayor, Kristen Starbuck, Emese Zsiros
Gynecologic Oncology. 2018-08-01 - 17 citationsTreatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveauKristen D. Starbuck, Linah Al-Alem, David A. Eavarone, Silvia F. Hernandez, Chiara Bellio
Oncotarget. 2018-05-01 - 8 citationsPrognostic impact of adjuvant chemotherapy treatment intensity for ovarian cancer.Kristen Starbuck, J. Brian Szender, William D. Duncan, Kayla Morrell, John Lewis Etter
Plos One. 2018-11-12
Journal Articles
- Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the LiteratureStarbuck KD, Drake RD, Budd GT, Rose PG, Anticancer Res, 1/1/2016
- Patterns of Care, Predictors and Outcomes of Chemotherapy for Uterine Carcinosarcoma: A population-based analysisRauh-Hain JA, Starbuck KD, Clemmer J, Schorge JO, Lu KH, del Carmen MG, Gynecol Oncol, 1/1/2015
- Multimodal therapy in the treatment of vaginal adenocarcinoma arising in endocervicosisStarbuck K, Garcia C, Wu Q, Runowicz CD, Gynecol Oncol, 1/1/2011
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Variability in body mass index during adjuvant chemotherapy is associated with clinical outcomes among patients with ovarian cancer undergoing adjuvant chemotherapyStarbuck KD, Cannioto R, Etter JL, Duncan W, Morrell K, Almohanna H, Joseph JM, Szender JB, Odunsi K, Lele S, Frederick P, Akers S, Eng KH, Zsiros E, Moysich KB, SGO, 1/1/2018
- Prognostic impact of adjuvant chemotherapy treatment intensity for ovarian cancerStarbuck KD, Szender JB, Morrell K, Etter JH, Odunsi K, Eng KH, Zsiros E, SGO, 1/1/2018
- Join now to see all
Press Mentions
- Five Reasons to Schedule Your Next Pap SmearAugust 24th, 2021
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: